Prostaglandin and Transforming Growth Factor β Signaling in Gastric Cancer

  • Masanobu Oshima
  • Hiroko Oshima
  • Makoto Mark Taketo


Gastric Cancer Pylorus Infection Gastric Cancer Cell Gastric Adenocarcinoma Gastric Epithelial Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Akre, K., Ekstrom, A. M., Signorello, L. B., Hansson, L. E., and Nyren, O. (2001). Aspirin and risk for gastric cancer: a population-based case-control study in Sweden. Br. J. Cancer 84:965–968.PubMedGoogle Scholar
  2. Al-Marhoon, M. S., Nunn, S., and Soames, R. W. (2004). CagA+ Helicobacter pylori induces greater levels of prostaglandin E2 than cagA–strains. Prostaglandins Other Lipid Mediat. 73:181–189.Google Scholar
  3. Boivin, G. P., Molina, J. R., Ormsby, I., Stemmermann, G., and Doetschman, T. (1996). Gastric lesions in transforming growth factor beta-1 heterozygous mice. Lab. Invest. 74:513–518.PubMedGoogle Scholar
  4. Chang, J., Park, K., Bang, Y.-J., Kim, W. S., Kim, D., and Kim, S.-J. (1997). Expression of transforming growth factor β type II receptor reduced tumorigenicity in human gastric cancer cells. Cancer Res. 57:2856–2859.PubMedGoogle Scholar
  5. Chang, Y.-J., Wu, M.-S., Lin, J.-T., and Chen, C.-C. (2005). Helicobacter pylori-induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/ TLR9 and promoter regulation. J. Immunol. 175:8242–8252.PubMedGoogle Scholar
  6. Chang, Y. J., Wu, M. S., Lin, J. T., Sheu, B. S., Muta, T., Inoue, H., and Chen,C.-C. (2004). Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-κB activation. Mol. Pharmacol. 66:1465–1477.PubMedGoogle Scholar
  7. Chen, C.-N., Sung, C.-T., Lin, M.-T., Lee, P.-H., and Chang, K.-J. (2001). Clinicopathologic association of cyclooxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinoma. Ann. Surg. 233:183–188.PubMedGoogle Scholar
  8. Cheng, X.-X., Wang, Z.-C., Chen, X.-Y., Sun, Y., Kong, Q.-Y., Liu, J., and Li, H. (2005). Correlation of Wnt-2 expression and β-catenin intracellular accumulation in Chinese gastric cancers: relevance with tumour dissemination. Cancer Lett. 223:339–347.PubMedGoogle Scholar
  9. Chi, X.-Z., Yang, J.-O., Lee, K.-Y., Ito, K., Sakakura, C., Li, Q.-L., Kim, H.-R., Cha, E.-J., Lee, Y.-H., Kaneda, A., Ushijima, T., Kim, W.-J., Ito, Y., and Bae, S.-C. (2005). RUNX3 suppresses gastric epithelial cell growth by inducing p21WAF1/CIP1 expression in cooperation with transforming growth factor β-activated SMAD. Mol. Cell. Biol. 25:8097–8107.PubMedGoogle Scholar
  10. Chulada, P. C., Thompson, M. B., Mahler, J. F., Doyle, C. M., Gaul, B. W., Lee, C., Tiano, H. F., Morham, S. G., Smithies, O., and Langenbach, R. (2000). Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res. 60:4705–4708.PubMedGoogle Scholar
  11. Clements, W. M., Wang, J., Sarnaik, A., Kim, O. J., MacDonald, J., Fenoglio-Preiser, C., Groden, J., and Lowy, A. M. (2002). β-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res. 62:3503–3506.PubMedGoogle Scholar
  12. Correa, P. (2003). Helicobacter pylori infection and gastric cancer. Cancer Epidemiol. Biomarkers Prev. 12:238s–241s.PubMedGoogle Scholar
  13. Derynck, R., Akhurst, R. J., and Balmain, A. (2001). TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 29:117–129.PubMedGoogle Scholar
  14. Dewitt, D. L., and Smith, W. L. (1998). Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc. Natl. Acad. Sci. USA 85:1412–1416.Google Scholar
  15. Ebert, M. P. A., Fei, G., Kahmann, S., Müller, O., Yu, J., Sung, J. J. Y., and Malfertheiner, P. (2002). Increased β-catenin mRNA levels and mutational alterations of the APC and β-catenin gene are present in intestinal-type gastric cancer. Carcinogenesis 23:87–91.PubMedGoogle Scholar
  16. Engle, S. J., Ormsby, I., Pawlowski, S., Boivin, G. P., Croft, J., Balish, E., and Doetschman, T. (2002). Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. Cancer Res. 62:6362–6366.PubMedGoogle Scholar
  17. Fletcher, B. S., Kujubu, D. A., Perrin, D. M., and Herschman, H. R. (1992). Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J. Biol. Chem. 267:4338–4344.Google Scholar
  18. Fu, Y.-G., Sung, J. J. Y., Wu, K.-C., Wu, H.-P., Yu, J., Chan, M., Chan, V. Y. W., Chan, K.-K., Fan, D.-M., and Leung, W. K. (2005). Inhibition of gastric cancer-associated angiogenesis by antisense COX-2 transfectants. Cancer Lett. 224:243–252.PubMedGoogle Scholar
  19. Futagami, S., Suzuki, K., Hiratsuka, T., Shindo,T., Hamamoto, T., Tatsuguchi, A., Ueki, N., Shinji, Y., Kusunoki, M., Wada, K., Miyake, K., Gudis, K., Tsukui,T., and Sakamoto, C. (2006). Celecoxib inhibits Cdx2 expression and prevents gastric cancer in Helicobacter pylori-infected mongolian gerbils. Digestion 74:187–198.PubMedGoogle Scholar
  20. Gregorieff, A., and Clevers, H. (2005). Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev. 19:877–890.PubMedGoogle Scholar
  21. Gupta, R. A., and DuBois, R. N. (2001). Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev. Cancer 1:11–21.PubMedGoogle Scholar
  22. Hahm, K.-B., Lee, K. M., Kim. Y. B., Hong, W. S., Lee, W. H., Han, S. U., Kim, M. W., Ahn, B. O., Oh, T. Y., Lee, M. H., Green, J., and Kim, S. J. (2002). Conditional loss of TGF-β signaling leads to increased susceptibility to gastrointestinal carcinogenesis in mice. Aliment. Pharmacol. Ther. 16:115–127.PubMedGoogle Scholar
  23. Han, S.-U., Kim, H.-T., Seong, D. H., Kim, Y.-S., Park, Y.-S., Bang, Y.-J., Yang, H.-K., and Kim, S.-J. (2004). Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer. Oncogene 23:1333–1341.PubMedGoogle Scholar
  24. Hanai, J., Chen, L. F., Kanno, T., Ohtani-Fujita, N., Kim, W. Y., Guo, W.-H., Imamura, T., Ishidou, Y., Fukuchi, M., Shi, M.-J., Stavnezer, J., Kawabata, M., Miyazono, K., and Ito, Y. (1999). Interaction and functional cooperation of PEBP2/CBF with Smads. J. Biol. Chem. 44:31577–31582.Google Scholar
  25. Haramis, A.-P. G., Begthel, H., van den Born, M., van Es, J., Jonkheer, S., Offerhaus, G. J. A., and Clevers, H. (2004). De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 303:1684–1686.PubMedGoogle Scholar
  26. Hla, T., and Neilson, K. (1992). Human cylooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA 89:7384–7388.PubMedGoogle Scholar
  27. Hohenstein, P., Molenaar, L., Elsinga, J., Morreau, H., van der Klift, H., Struijk, A., Jagmohan- Changur, S., Smits, R., van Kranen, H., van Ommen, G.-J. B., Cornelisse, C., Devilee, P., and Fodde, R. (2003). Serrated adenomas and mixed polyposis caused by a splice acceptor deletion in the mouse Smad4 gene. Genes Chromosomes Cancer 36:273–282.PubMedGoogle Scholar
  28. Houghton, J., Stoicov, C., Nomura, S., Rogers, A. B., Carlson, J., Li, H., Cai, X., Fox, J. G., Goldenring, J. R., and Wang, T. C. (2004). Gastric cancer originating from bone marrow- derived cells. Science 306:1568–1571.PubMedGoogle Scholar
  29. Howe, J. R., Bair, J. L., Sayed, M. G., Anderson, M. E., Mitros, F. A., Petersen, G. M., Velculescu, V. E., Traverso, G., and Vogelstein, B. (2001). Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat. Genet. 28:184–187.PubMedGoogle Scholar
  30. Hu, P. J., Yu, J., Zeng, Z. R., Leung, W. K., Lin, H. L., Tang, B. D., Bai, A. H. C., and Sung, J. J. Y. (2004). Chemoprevention of gastric cancer by celecoxib in rats. Gut 53:195–200.PubMedGoogle Scholar
  31. Ito, Y., and Miyazono, K. (2003). RUNX transcription factors as key targets of TGF-β super- family signaling. Curr. Opin. Genet. Dev. 13:43–47.PubMedGoogle Scholar
  32. Jang, T. J. (2004). Expression of proteins related to prostaglandin E2 biosynthesis is increased in human gastric cancer and during gastric carcinogenesis. Virchows Arch. 445:564–571.PubMedGoogle Scholar
  33. Jenkins, B. J., Graio, D., Nheu, T., Najdovska, M., Wang, B., Waring, P., Inglese, M., McLoughlin, R. M., Jones, S. A., Topley, N., Baumann, H., Judd, L. M., Giraud, A. S., Boussioutas, A., Zhu, H.-J., and Ernst, M. (2005). Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling. Nat. Med. 11:845–852.PubMedGoogle Scholar
  34. Jin, G., Wang, L., Chen, W., Hu, Z., Zhou, Y., Tan, Y., Wang, J., Hua, Z., Ding, W., Shen, J., Zhang, Z., Wang, X., Xu, Y., and Shen, H. (2007). Variant alleles of TGFB1 and TGFBR2 are associated with a decreased risk of gastric cancer in a Chinese population. Int. J. Cancer 120:1330–1335.PubMedGoogle Scholar
  35. Joo, Y.-E., Rew, J.-S., Seo, Y.-H., Choi, S.-K., Kim, Y.-J., Park, C.-S., and Kim, S.-J. (2003). Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer. J. Clin. Gastroenterol. 37:28–33.PubMedGoogle Scholar
  36. Kang, S. H., Bang, Y.-J., Im, Y.-H., Yang, H.-K., Lee, D. A., Lee, H. Y., Lee, H. S., Kim, N. K., and Kim, S.-J. (1999). Transcriptional repression of the transforming growth factor-β type I receptor gene by DNA methylation results in the development of TGF-β resistance in human gastric cancer. Oncogene 18:7280–7286.PubMedGoogle Scholar
  37. Kawada, M., Seno, H., Wada, M., Suzuki, K., Kanda, N., Kayahara, T., Fukui, H., Sawada, M., Kajiyama, T., Sakai, M., and Chiba, T. (2003). Cyclooxygenase-2 expression and angiogen-esis in gastric hyperplastic polyp-association with polyp size. Digestion 67:20–24.PubMedGoogle Scholar
  38. Kim, Y. H., Lee, H. S., Lee, H.-J., Hur, K., Kim, W. H., Bang, Y.-J., Kim, S.-J., Lee, K. U., Choe, K. J., and Yang, H.-K. (2004). Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas. Ann. Oncol. 15:574–580.PubMedGoogle Scholar
  39. Kim, J. Y., Park, D. Y., Kim, G. H., Choi, K. U., Lee, C. H., Huh, G. Y., Sol, M. Y., Song, G. A., Jeon, T. Y., Kim, D. H., and Sim, M. S. (2005). Smad4 expression in gastric adenoma and adenocarcinoma: frequent loss of expression in diffuse type of gastric adenocarcinoma. Histol. Histopathol. 20:543–549.PubMedGoogle Scholar
  40. Kim, C. J., Song, J. H., Cho, Y. G., Kim, Y. S., Kim, S. Y., Nam, S. W., Yoo, N. J., Lee, J. Y., and Park, W. S. (2007). Somatic mutations of the β-TrCP gene in gastric cancer. APMIS 115:127–133.PubMedGoogle Scholar
  41. Kitamura, T., Kometani, K., Hashida, H., Matsunaga, A., Miyoshi, H., Hosogi, H., Aoki, M., Oshima, M., Hattori, M., Takabayashi, A., Minato, N., and Taketo, M. M. (2007). Smad4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion. Nat. Genet. 39:467–475.PubMedGoogle Scholar
  42. Langman, M. J., Cheng, K. K., Gilman, E. A., and Lancashire, R. J. (2000). Effect of anti- inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ 320:1642–1646.PubMedGoogle Scholar
  43. Leung, W. K., To, K. F., Go, M. Y., Chan, K. K., Chan, F. K., Ng, E. K., Chung, S. C., and Sung, J. J. (2003). Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma. Int. J. Oncol. 23:1317–1322.PubMedGoogle Scholar
  44. Li, Q.-L., Ito, K., Sakakura, C., Fukamachi, H., Inoue, K., Chi, X.-Z., Lee, K.-Y., Nomura, S., Lee, C.-W., Han, S.-B., Kim, H.-M., Kim, W.-J., Yamamoto, H., Yamashita, N., Yano, T., Ikeda, T., Itohara, S., Inazawa, J., Abe, T., Hagiwara, T., Yamagishi, H., Ooe, A., Kaneda, A., Sugimura, T., Ushijima, T., Bae, S.-C., and Ito, Y. (2002). Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109:113–124.PubMedGoogle Scholar
  45. Lim, H.Y., Joo, H. J., Choi, J. H., Yi, J. W., Yang, M. S., Cho, D. Y., Kim, H. S., Nam, D. K., Lee, K. B., and Kim, H. C. (2000). Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clin. Cancer Res. 6:519–525.PubMedGoogle Scholar
  46. Lim, J. W., Kim, H., and Kim, K. H. (2001). Nuclear factor-kappaB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells. Lab. Invest. 81:349–360.PubMedGoogle Scholar
  47. Lin, Y., Kikuchi, S., Obata, Y., Yagyu, K., and The Tokyo Research Group on Prevention of Gastric Cancer. (2006). Serum levels of transforming growth factor β1 are significantly correlated with venous invasion in patients with gastric cancer. J. Gastroenterol. Hepatol. 21:432–437.PubMedGoogle Scholar
  48. Liu, F., Pan, K., Zhang, X., Zhang, Y., Zhang, L., Ma, J., Dong, C., Shen, L., Li, J., Deng, D., Lin, D., and You, W. (2006). Genetic variants in cyclooxygenase-2: expression and risk of gastric cancer and its precursors in a Chinese population. Gastroenterology 130:1975–1984.PubMedGoogle Scholar
  49. Lowy, A. M., Clements, W. M., Bishop, J., Kong, L., Bonney, T., Sisco, K., Aronow, B., Fenoglio- Preiser, C., and Groden, J. (2006). β-Catenin/Wnt signaling regulates expression of the membrane type3 matrix metalloproteinase in gastric cancer. Cancer Res. 66:4734–4741.PubMedGoogle Scholar
  50. Magari, H., Shimizu, Y., Inada, K., Enomoto, S., Tomeki, T., Yanaoka, K., Tamai, H., Arii, K., Nakata, H., Oka, M., Utsunomiya, H., Tsutsumi, Y., Tsukamoto,T., Tatematsu, M., and Ichinose, M. (2005). Inhibitory effects of etodolac, a selective cyclooxygenase-2 inhibitor, on stomach carcinogenesis in Helicobacter pylori-infected mongolian gerbils. Biochem. Biophys. Res. Commun. 334:606–612.PubMedGoogle Scholar
  51. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Willson, J. K. V. (1995). Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268:1336–1338.PubMedGoogle Scholar
  52. Matsumoto,Y., Marusawa, H., Kinoshita, K., Endo, Y., Kou, T., Morisawa, T., Azuma, T., Okazaki, I.-M., Honjo, T., and Chiba, T. (2007). Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat. Med. 13:470–476.PubMedGoogle Scholar
  53. McCarthy, C. J., Crofford, L. J., Greenson, J., and Scheiman, J. M. (1999). Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection. Am. J. Gastroenterol. 94:1218–1223.PubMedGoogle Scholar
  54. Miyazawa, K., Iwaya, K., Kuroda, M., Harada, M., Serizawa, H., Koyanagi, Y., Sato, Y., Mizokami, Y., Matsuoka, T., and Mukai, K. (2000). Nuclear accumulation of beta-catenin in intestinal-type gastric carcinoma: correlation with early tumor invasion. Virchows Arch. 437:508–513.PubMedGoogle Scholar
  55. Miyazono, K., Maeda, S., and Imamura, T. (2005). BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 16:251–263.PubMedGoogle Scholar
  56. Mrena, J., Wiksten, J.-P., Thiel, A., Kokkola, A., Pohjola, L., Lundin, J., Nordling, S., Ristimäki, A., and Haglund, C. (2005). Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR. Clin. Cancer Res. 11:7362–7368.PubMedGoogle Scholar
  57. Murakami, M., Naraba, H., Tanioka, T., Semmyo, N., Nakatani, Y., Kojima, F., Ikeda, T., Fueki, M., Ueno, A., Oh-ishi, S., and Kudo, I. (2000). Regulation of prostaglandin E2 biosynthesis by induc-ible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275:32783–32792.PubMedGoogle Scholar
  58. Murata, H., Kawano, S., Tsuji, S., Tsuji, M., Sawaoka, H., Kimura, Y., Shiozaki, H., and Hori, M. (1999). Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am. J. Gastroenterol. 94:451–455.PubMedGoogle Scholar
  59. Myeroff, L. L., Parsons, R., Kim, S.-J., Hedrick, L., Cho, K. R., Orth, K., Mathis, M., Kinzler, K. W., Lutterbaugh, J., Park, K., Bang, Y.-J., Lee, H. Y., Park, J.-G., Lynch, H. T., Roberts, A. B., Vogelstein, B., and Markowitz, S. D. (1995). A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatel- lite instability. Cancer Res. 55:5545–5547.PubMedGoogle Scholar
  60. Nakajima, T., Maekita, T., Oda, I., Gotoda, T., Yamamoto, S., Umemura, S., Ichinose, M., Sugimura, T., Ushijima, T., and Saito, D. (2006). Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers. Cancer Epidemiol. Biomarkers Prev. 15:2317–2321.PubMedGoogle Scholar
  61. Nam, K. T., Hahm, K.-B., Oh, S.-Y., Yeo, M., Han, S.-U., Ahn, B., Kim, Y.-B., Kang, J. S., Jang, D. D., Yang, K.-H., and Kim, D.-Y. (2004). The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model. Clin. Cancer Res. 10:8105–8113.PubMedGoogle Scholar
  62. Nardone, G., Rocco, A., Vaira, D., Staibano, S., Budillon, A., Tatangelo, F., Sciulli, M. G., Perna, F., Salvatore, G., Di Benedetto, M., De Rosa, G., and Patrignani, P. (2004). Expression of COX-2, mPGE-synthase1, MDR-1(P-gp), and Bcl-XL: a molecular pathway of H. pylori-related gastric carcinogenesis. J. Pathol. 202:305–312.Google Scholar
  63. Narita, T., Saitoh, K., Kameda, T., Kuroiwa, A., Mizutani, M., Koike, C., Iba, H., and Yasugi, S. (2000). BMPs are necessary for stomach gland formation in the chicken embryo: a study using virally induced BMP-2 and Noggin expression. Development 127:981–988.PubMedGoogle Scholar
  64. Nojima, M., Suzuki, H., Toyota, M., Watanabe, Y., Maruyama, R., Sasaki, S., Sasaki, Y., Mita, H., Nishikawa, N., Yamaguchi, K., Hirata, K., Itoh, F., Tokino, T., Mori, M., Imai, K., and Shinomura, Y. (2007). Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer. Oncogene 26(32):4699–4713.PubMedGoogle Scholar
  65. Nomura, S., Baxter, T., Yamaguchi, H., Leys, C., Vartapetian, A. B., Fox, J. G., Lee, J. R., Wang, T. C., and Goldenring, J. R. (2004). Spasmolytic polypeptide expressing metaplasia to preneo-plasia in H. felis-infected mice. Gastroenterology 127:582–594.Google Scholar
  66. Offerhaus, G. J., Giardiello, F. M., Krush, A. J., Booker, S. V., Tersmette, A. C., Kelley, N. C., and Hamilton, S. R. (1992). The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 102:1980–1982.PubMedGoogle Scholar
  67. Ohno, R., Yoshinaga, K., Fujita, T., Hasegawa, K., Iseki, H., Tsunozaki, H., Ichikawa, W., Nihei, Z., and Sugihara, K. (2001). Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer 91:1876–1881.PubMedGoogle Scholar
  68. Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., and Taketo, M. M. (1996). Suppression of intestinal polyposis in ApcΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87:803–809.PubMedGoogle Scholar
  69. Oshima, H., Matsunaga, A., Fujimura, T., Tsukamoto, T., Taketo, M. M. and Oshima, M. (2006). Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and pros-taglandin E2 pathway. Gastroenterology 131:1086–1095.PubMedGoogle Scholar
  70. Oshima, H., Oshima, M., Inaba, K., and Taketo, M. M. (2004). Hyperplastic gastric tumors induced by activated macrophages in COX-2 /mPGES-1 transgenic mice. EMBO J. 23:1669–1678.PubMedGoogle Scholar
  71. Oshima, M., Oshima, H., Kitagawa, K., Kobayashi, M., Itakura, C., and Taketo M. (1995). Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl. Acad. Sci. USA 92:4482–4486.PubMedGoogle Scholar
  72. Oshima, H., Oshima, M., Kobayashi, M., Tsutsumi, M., and Taketo, M. M. (1997). Morphological and molecular processes of polyp formation in ApcΔ716 knockout mice. Cancer Res. 57:1644–1649.PubMedGoogle Scholar
  73. Oshima, M., Oshima, H., Matsunaga, A., and Taketo, M. M. (2005). Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-α-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 trans- genic mice. Cancer Res. 65:9147–9151.PubMedGoogle Scholar
  74. Oshima, M., and Taketo, M. M. (2002). COX selectivity and animal models for colon cancer. Curr. Pharm. Des. 8:1021–1034.PubMedGoogle Scholar
  75. Pai, R., Soreghan, B., Szabo, I. L., Pavelka, M., Baatar, D., and Tarnawski, A. S. (2002). Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat. Med. 8:289–293.PubMedGoogle Scholar
  76. Park, K., Kim, S.-J., Bang, Y.-J., Park, J.-G., Kim, N. K., Roberts, A, B., and Sporn, M. B. (1994). Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad. Sci. USA 91:8772–8776.PubMedGoogle Scholar
  77. Park, W. S., Oh, R. R., Park, J. Y., Lee, S. H., Shin, M. S., Kim, Y. S., Kim, S. Y., Lee, H. K., Kim, P. J., Oh, S. T., Yoo, N, J., and Lee, J. Y. (1999). Frequent somatic mutations of the β-catenin gene in intestinal-type gastric cancer. Cancer Res. 59:4257–4260.PubMedGoogle Scholar
  78. Parsons, R., Myeroff, L. L., Liu, B., Willson, J. K. V., Markowitz, S. D., and Kinzler, K. W. (1995). Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res. 55:5548–5550.PubMedGoogle Scholar
  79. Pinto, M., Oliveira, C., Cirnes, L., Machado, J. C., Ramires, M., Nogueira, A., Carneiro, F., and Seruca, R. (2003). Promoter methylation of TGFβ receptor I and mutation of TGFβ receptor II are frequent events in MSI sporadic gastric carcinomas. J. Pathol. 200:32–38.PubMedGoogle Scholar
  80. Ristimäki, A., Honkanen, N., Jänkälä, H., Sipponen, P., and Härkönen, M. (1997). Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res. 57:1276–1280.PubMedGoogle Scholar
  81. Saito, H., Tsujitani, S., Oka, S., Kondo, A., Ikeguchi, M., Maeta, M., and Kaibara, N. (1999). The expression of transforming growth factor-β1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. Cancer 86:1455–1462.PubMedGoogle Scholar
  82. Sakakura, C., Hasegawa, K., Miyagawa, K., Nakashima, S., Yoshikawa, T., Kin, S., Nakase, Y., Yazumi, S., Yamagishi, H., Okanoue, T., Chiba, T., and Hagiwara, A. (2005). Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers. Clin. Cancer Res. 11:6479–6488.PubMedGoogle Scholar
  83. Saukkonen, K., Nieminen, O., van Rees, B., Vilkki, S., Härkönen, M., Juhola, M., Mecklin, J.-P., Sipponen, P., and Ristimäki, A. (2001). Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma. Clin. Cancer Res. 7:1923–1931.PubMedGoogle Scholar
  84. Saukkonen, K., Rintahaka, J., Sivula, A., Buskens, C. J., van Rees, B. P., Rio, M.-C., Haglund, C., van Lanschot, J. J. B., Offerhaus, G. J. A., and Ristimäki, A. (2003). Cyclooxygenase-2 and gastric carcinogenesis. APMIS 111:915–925.Google Scholar
  85. Sawaoka, H., Kawano, S., Tsuji, S., Tsujii, M., Gunawan, E. S., Takei, Y., Nagano, K., and Hori, M. (1998). Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am. J. Physiol. 274:G1061–1067.PubMedGoogle Scholar
  86. Schreinemachers, D. M., and Everson, R. B. (1994). Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5:138–146.Google Scholar
  87. Seno, H., Oshima, M., Ishikawa, T., Oshima, H., Takaku, K., Chiba, T., Narumiya, S., and Taketo, M. M. (2002). Cyclooxygeanse-2 and prostaglandin E2 receptor EP2-dependent angiogenesis in ApcΔ716 mouse intestinal polyps. Cancer Res. 62:506–511.PubMedGoogle Scholar
  88. Shao, J., Sheng, H., Aramandla, R., Pereira, M. A., Lubet, R. A., Hawk, E., Grogan, L., Kirsch, I. R., Washington, M. K., Beauchamp, R. D., and DuBois, R. N. (1999). Coordinate regulation of cyclooxygenase-2 and TGF-β1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors. Carcinogenesis 20:185–191.PubMedGoogle Scholar
  89. Shen, H., Sun, W.-H., Xue, Q.-P., Wu, J., Cheng, Y.-L., Ding, G.-X., Fu, H.-Y., Tsuji, S., and Kawano, S. (2006). Influences of Helicobacter pylori on cyclooxygenase-2 expression and prostaglandinE2 synthesis in rat gastric epithelial cells in vitro. J. Gastroenterol. Hepatol. 21:754–758.PubMedGoogle Scholar
  90. Sheng, H., Shao, J., Dixon, D. A., Williams, C. S., Prescott, S. M., DuBois, R. N., and Beauchamp, R. D. (2000). Transforming growth factor-β1 enhances Ha-ras-induced expression of cycloox-ygenase-2 in intestinal epithelial cells via stabilization of mRNA. J. Biol. Chem. 275:6628–6635.PubMedGoogle Scholar
  91. Shi, Y., and Massagué, J. (2003). Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685–700.PubMedGoogle Scholar
  92. Shi, H., Xu, J.-M., Hu, N.-Z., and Xie, H.-J. (2003). Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma. World J. Gastroenterol. 9:1421–1426.PubMedGoogle Scholar
  93. Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C, Proetzel, G., Calvin, D., Annunziata, N., and Doetschman, T. (1992). Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693–699.PubMedGoogle Scholar
  94. Smith, M. F., Jr., Mitchell, A., Li, G., Ding, S., Fitzmaurice, A. M., Ryan, K., Crowe, S., and Goldberg, J. B. (2003). Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kB activation and chemokine expression by epithelial cells. J. Biol. Chem. 278:32552–32560.PubMedGoogle Scholar
  95. Sonoshita, M., Takaku, K., Sasaki, N., Sugimoto, Y., Ushikubi, F, Narumiya, S., Oshima, M., and Taketo, M. M. (2001). Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice. Nat. Med. 7:1048–1051.PubMedGoogle Scholar
  96. Stichtenoth, D. O., Thorén, S., Bian, H., Peters-Golden, M., Jakobsson, P.-J., and Crofford, L. J. (2001). Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells. J. Immunol. 167:469–474.PubMedGoogle Scholar
  97. Sun, W.-H., Yu, Q., Shen, H., Ou, X.-L., Cao, D.-Z., Yu, T, Qian, C, Zhu, F, Sun, Y.-L., Fu, X.-L., and Su, H. (2004). Roles of Helicobacter pylori infection and cyclooxygenase-2 expression in gastric carcinogenesis. World J. Gastroenterol. 10:2809–2813.PubMedGoogle Scholar
  98. Sung, J. J. Y, Leung, W. K., Go, M. Y Y, To, K. F, Cheng, A. S. L., Ng, E. K. W., and Chan, F K. L. (2000). Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am. J. Pathol. 157:729–735.PubMedGoogle Scholar
  99. Takaku, K., Miyoshi, H., Matsunaga, A., Oshima, M., Sasaki, N., and Taketo, M. M. (1999). Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice. Cancer Res. 59:6113–6117.PubMedGoogle Scholar
  100. Taketo, M. M. (2006). Wnt signaling and gastrointestinal tumorigenesis in mouse models. Oncogene 25:7522–7530.PubMedGoogle Scholar
  101. Takeda, H., Miyoshi, H., Tamai, Y, Oshima, M., and Taketo, M. M. (2004). Simultaneous expression of COX-2 and mPGES-1 in mouse gastrointestinal hamartomas. Br. J. Cancer 90:701–704.PubMedGoogle Scholar
  102. Tang, C, Liu, C, Zhou, X., and Wang, C. (2004). Enhanced inhibitive effects of combination of rofecoxib and octreotide on the growth of human gastric cancer. Int. J. Cancer 112:470–474.PubMedGoogle Scholar
  103. Tatsuguchi, A., Matsui, K., Shinji, Y, Gudis, K., Tsukui, T, Kishida, T, Fukuda, Y, Sugisaki, Y, Tokunaga, A., Tajiri, T, and Sakamoto, C. (2004). Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue. Hum. Pathol. 35:488–495.PubMedGoogle Scholar
  104. Tebbutt, N. C, Giraud, A. S., Inglese, M., Jenkins, B., Waring, P., Clay, F J., Malki, S., Alderman, B. M., Grail, D., Hollande, F, Heath, J. K., and Ernst, M. (2002). Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 8:1089–1097.PubMedGoogle Scholar
  105. Thiel, A., Heinonen, M., Rintahaka, J., Hallikainen, T, Hemmes, A., Dixon, D. A., Haglund, C, and Ristimäki, A. (2006). Expression of cyclooxygenase-2 is regulated by glycogen synthase kinase-3|3 in gastric cancer cells. J. Biol. Chem. 281:4564–4569.PubMedGoogle Scholar
  106. Thun, M. J., Namboodiri, M. M., Calle, E. E., Flanders, W D., and Heath, C. W, Jr. (1993). Aspirin use and risk of fatal cancer. Cancer Res. 53:1322–1327.PubMedGoogle Scholar
  107. Thun, M. J., Namboodiri, M. M., and Heath, C. W, Jr. (1991). Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 325:1593–1596.PubMedGoogle Scholar
  108. Tsujii, M., and DuBois, R. N. (1995). Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83:493–501.PubMedGoogle Scholar
  109. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R. N. (1998). Cyclooxygenase regulates angiogenesis induced colon cancer cells. Cell 93:705–716.PubMedGoogle Scholar
  110. Uefuji, K., Ichikura, T, and Mochizuki, H. (2000). Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer. Clin. Cancer Res. 6:135–138.PubMedGoogle Scholar
  111. van Rees, B. P., Saukkonen, K., Ristimäki, A., Polkowski, W, Tytgat, G. N. J., Drillenburg, P., and Offerhaus, G. J. A. (2002). Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J. Pathol. 196:171–179.PubMedGoogle Scholar
  112. van Rees, B. P., Sivula, A., Thorén, S., Yokozaki, H., Jakobsson, P.-J., Offerhaus, J. A., and Ristimäki, A. (2003). Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines. Int. J. Cancer 107:551–556.Google Scholar
  113. Wen, X.-Z., Akiyama, Y., Baylin, S., and Yuasa, Y. (2006). Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas. Oncogene 25:2666–2673.PubMedGoogle Scholar
  114. Wen, X.-Z., Miyake, S., Akiyama, Y., and Yuasa, Y. (2004). BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells. Biochem. Biophys. Res. Commun. 316:100–106.PubMedGoogle Scholar
  115. Woo, D. K., Kim, H. S., Lee, H. S., Kang, Y. H., Yang, H. K., and Kim, W. H. (2001). Altered expression and mutation of β-catenin gene in gastric carcinomas and cell lines. Int. J. Cancer 95:108–113.PubMedGoogle Scholar
  116. Wu, Y.-L., Fu, S.-L., Zhang, Y.-P., Qiao, M.-M., and Chen, Y. (2005). Cyclooxygenase-2 inhibitors suppress angiogenesis and growth of gastric cancer xenografts. Biomed. Pharmacother. 59:S289–S292.PubMedGoogle Scholar
  117. Xiangming, C., Natsugoe, S., Takao, S., Hokita, S., Ishigami, S., Tanabe, G., Baba, M., Kuroshima, K., and Aikou, T. (2001). Preserved Smad4 expression in the transforming growth factor β signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer. Clin. Cancer Res. 7:277–282.PubMedGoogle Scholar
  118. Xiao, F., Furuta, T., Takashima, M., Shirai, N., and Hanai, H. (2001). Involvement of cyclooxy-genase-2 in hyperplastic gastritis induced by Helicobacter pylori infection in C57BL/6 mice. Aliment. Pharmacol. Ther. 15:875–886.PubMedGoogle Scholar
  119. Xie, W. L., Chipman, J. G., Robertson, D. L., Erikson, R. L., and Simmons, D. L. (1991). Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. USA 88:2692–2696.PubMedGoogle Scholar
  120. Xu, X., Brodie, S. G., Yang, X., Im, Y.-H., Parks, W. T., Chen, L., Zhou, Y.-X., Weinstein, M., Kim, S.-J., and Deng, C.-X. (2000). Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice. Oncogene 19:1868–1874.PubMedGoogle Scholar
  121. Yamagata, R., Shimoyama, T., Fukuda, S., Yoshimura, T., Tanaka, M., and Munakata, A. (2002). Cyclooxygenase-2 expression is increased in early intestinal-type gastric cancer and gastric mucosa with intestinal metaplasia. Eur. J. Gastroenterol. Hepatol. 14:359–363.PubMedGoogle Scholar
  122. Yang, H.-K., Kang, S. H., Kim, Y.-S., Won, K., Bang, Y.-J., and Kim. S.-J. (1999). Truncation of the TGF-β type II receptor gene results in insensitivity to TGF-β in human gastric cancer cells. Oncogene 18:2213–2219.PubMedGoogle Scholar
  123. Yano, T., Ito, K., Fukamachi, H., Chi, X.-Z., Wee, H.-J., Inoue, K., Ida, H., Bouillet, P., Strasser, A., Bae, S.-C., and Ito, Y. (2006). The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor β-induced apoptosis. Mol. Cell. Biol. 26:4474–4488.PubMedGoogle Scholar
  124. Yoshimatsu, K., Golijanin, D., Paty, P. B., Soslow, R. A., Jakobsson, P.-J., DeLellis, R. A., Subbaramaiah, K., and Dannenberg, A. J. (2001). Inducible microsomal prostaglandin E syn-thase is overexpressed in colorectal adenomas and cancer. Clin. Cancer Res. 7:3971–3976.PubMedGoogle Scholar
  125. Yu, H.-G., Li, J.-Y., Yang, Y.-N., Luo, H.-S., Yu, J.-P., Meier, J. J., Schrader, H., Bastian, A., Schmidt, W. E., and Schmitz, F. (2003). Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer. Cancer Lett. 195:43–51.PubMedGoogle Scholar
  126. Zaridze, D., Borisova, E., Maximovitch, D., and Chkhikvadze, V. (1999). Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia. Int. J. Cancer 82:473–476.PubMedGoogle Scholar
  127. Zhou, Y., Ran, J., Tang, C., Wu, J., Honghua, L., Xingwen, L., Ning, C., and Qiao, L. (2007). Effect of celecoxib on E-cadherin, VEGF, microvessel density and apoptosis in gastric cancer. Cancer Biol. Ther. 6:269–275.PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2009

Authors and Affiliations

  • Masanobu Oshima
    • 1
  • Hiroko Oshima
    • 1
  • Makoto Mark Taketo
    • 2
  1. 1.Division of Genetics, Cancer Research InstituteKanazawa UniversityJapan
  2. 2.Department of PharmacologyKyoto University Graduate School of MedicineJapan

Personalised recommendations